HOPING HE IS INVESTING IN SECURITY AT THIS POINT…TPT STAFF
He sees 50% of patients achieve complete remission, with sufferers flocking to him from all over the world
TheDailyMail.com – Dolores Chang
Philip Salem, 82, combined immunotherapy, chemotherapy, and targeted therapy to create a breakthrough cancer treatment called ICTriplex. ‘I have been in cancer medicine for 55 years. I have never seen before what I’m seeing now as a result of ICTriplex,’ Salem told ABC7 . The 82-year-old oncologist, at the forefront of cancer research, published his findings in the American Society of Clinical Oncology Journal in June 2022. The compelling outcomes of his study drew desperate patients from around the world, traveling thousands of miles to Houston, Texas , in search of hope and the possibilities offered by this groundbreaking treatment.
Cancer patients have flocked from all over the world to a Houston oncologist who developed a cutting-edge treatment that achieves a complete remission in 50 percent of patients.
Philip Salem, 82, combined immunotherapy, chemotherapy, and targeted therapy to create a breakthrough cancer treatment called ICTriplex at his Salem Oncology Center.
‘I have been in cancer medicine for 55 years. I have never seen before what I’m seeing now as a result of ICTriplex,’ Salem told ABC7.
The 82-year-old oncologist, at the forefront of cancer research, published his findings in the American Society of Clinical Oncology Journal in June 2022.
The compelling outcomes of his study drew desperate patients from around the world, traveling thousands of miles to Houston, Texas, in search of hope and the possibilities offered by this groundbreaking treatment.
Bianca Gurrado, a patient who traveled from Italy to Houston, shared that she first learned about Dr. Salem around a year ago when her cancer was advancing and spreading.
‘I did start therapy in Italy, but unfortunately the results of the therapy were not well, so I was in constant progression of the disease.’
Gurrado, who battled the challenging disease for three years, is now in a state of complete remission, Salem said.
Petra, a cancer patient who called the treatment to a miracle, said: ‘I had a lot of pain in the beginning when I came here, and in the first month it was already gone.’
Salem’s oncology center is the only facility that uses the combination of immunotherapy, chemotherapy and targeted therapy in managing advanced cancer, the doctor said.
‘We took patients who were told by major cancer centers to go home and die, and we produced 50 to 60 percent complete remission rate.’
‘Zero percent against 50 percent, that’s an easy choice,’ cancer patient Marco Praagman said.